You will not be allowed to compare more than 4 products at a time
View compareDescription
OCTILIA ALLERGIA E INFIAMMAZIONE 3 mg/ml + 0.5 mg/ml eye drops, solution
Pheniramine maleate + Tetryzoline hydrochloride
What it is and what it is used for
OCTILIA ALLERGIA E INFIAMMAZIONE contains the active ingredients pheniramine maleate and tetryzoline hydrochloride.
Pheniramine maleate belongs to a group of medicines called "antihistamines" and works by counteracting allergy symptoms.
Tetryzoline hydrochloride belongs to a group of medicines called "decongestants" and works by reducing the dilation of blood vessels.
OCTILIA ALLERGIA E INFIAMMAZIONE is used to treat allergies and inflammations of the membrane of the eye (conjunctiva) accompanied by light hypersensitivity (photophobia), tearing, foreign body sensation, pain.
Consult your doctor if you do not feel better or if you feel worse after 4 days of treatment.
What you need to know before taking the medicine
Do not use OCTILIA ALLERGIA E INFIAMMAZIONE:
- if you are allergic to pheniramine maleate or tetryzoline hydrochloride or any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to other medicines of the same family as pheniramine maleate and tetryzoline hydrochloride, in particular xylometazoline, oxymetazoline, naphazoline;
- if you have a disease due to high pressure inside the eye (narrow/closed-angle glaucoma) or if you suffer from other serious eye diseases;
- if it is for a child under 12 years of age;
- if you are pregnant or breastfeeding (see "Pregnancy and breastfeeding");
- if you are concurrently being treated with medicines used for depression (monoamine oxidase inhibitors, such as tranylcypromine, phenelzine, pargyline) (see "Other medicines and OCTILIA ALLERGIA E INFIAMMAZIONE").
Warnings and precautions
Consult your doctor or pharmacist before using OCTILIA ALLERGIA E INFIAMMAZIONE:
- if you suffer from high blood pressure (hypertension);
- if you suffer from excessive activity of a gland called the thyroid (hyperthyroidism);
- if you have heart problems;
- if you have high blood sugar levels (hyperglycemia, diabetes);
- if you suffer from infections or pus in the eye;
- if you have foreign bodies in the eye;
- if you have various types of eye problems (mechanical, chemical, heat-related).
The use, especially prolonged, of topical medicines can cause allergies (sensitization phenomena). In such a case, your doctor will ask you to stop the treatment and will recommend appropriate therapy.
Do not use this medicine for more than 4 consecutive days, unless otherwise prescribed by a doctor, as undesirable effects may otherwise occur.
OCTILIA ALLERGIA E INFIAMMAZIONE in the multi-dose vial package contains benzalkonium chloride as a preservative, which can cause allergic reactions. During treatment, you should not wear contact lenses and can only wear them 15 minutes after using the medicine.
If you experience an allergy to benzalkonium chloride or wear contact lenses, you can use OCTILIA ALLERGIA E INFIAMMAZIONE in the single-dose container package which does not contain preservatives.
Children and adolescents
OCTILIA ALLERGIA E INFIAMMAZIONE should not be used in children under 12 years of age.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
During treatment with OCTILIA ALLERGIA E INFIAMMAZIONE, you may experience allergic reactions. In this case, IMMEDIATELY STOP treatment and contact your doctor who, if necessary, may give you suitable treatment. During treatment with OCTILIA ALLERGIA E INFIAMMAZIONE, you may also experience the following side effects:
Effects affecting the eye:
• pupil dilation;
• increased pressure inside the eye.
Effects affecting the whole body:
• increased blood pressure (hypertension);
• heart problems;
• increased blood sugar levels (hyperglycemia);
• nausea;
• headache.
In children, if accidentally ingested, the preparation can cause profound drowsiness (sopor) and decreased activity (hypotonia).
Rarely, hypersensitivity phenomena may occur. In such a case, stop the treatment and consult your doctor who, if necessary, will give you appropriate therapy.
Following the instructions in this leaflet reduces the risk of side effects.
Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.

